National Health (Price and Special Patient Contribution) Amendment Determination 2021 (No. 2) (PB 20 of 2021) (Cth)

PB 20 of 2021

National Health (Price and Special Patient Contribution) Amendment Determination 2021 (No. 2)

I, Thea Connolly, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated   24   February 2021                 

THEA CONNOLLY

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments  2

National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)              2

1  Name

This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2021 (No. 2).

This instrument may also be cited as PB 20 of 2021

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	1 March 2021.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under section 85B of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

1  Schedule 1, entry for Candesartan

Omit

Candesartan	Tablet containing candesartan cilexetil 4 mg	Oral	Atacand	30	0.43	12.96
Tablet containing candesartan cilexetil 8 mg	Oral	Atacand	30	1.29	13.82
Tablet containing candesartan cilexetil 16 mg	Oral	Atacand	30	3.84	16.37
Tablet containing candesartan cilexetil 32 mg	Oral	Atacand	30	4.64	17.17

Substitute

Candesartan	Tablet containing candesartan cilexetil 4 mg	Oral	Atacand	30	0.43	12.96
Tablet containing candesartan cilexetil 8 mg	Oral	Atacand	30	1.29	13.82
Tablet containing candesartan cilexetil 32 mg	Oral	Atacand	30	4.64	17.17

2  Schedule 1, entry for Quinapril

Omit

Quinapril	Tablet 5 mg (as hydrochloride)	Oral	Accupril	30	2.91	6.82
Tablet 10 mg (as hydrochloride)	Oral	Accupril	30	3.71	7.62

Substitute

Quinapril Tablet 10 mg (as hydrochloride) Oral Accupril 30 3.71 7.62

3  Schedule 1, entry for Sertraline

Omit

Sertraline	Tablet 50 mg (as hydrochloride)	Oral	Zoloft	30	1.57	6.97
Tablet 100 mg (as hydrochloride)	Oral	Zoloft	30	1.57	6.97

Substitute

Sertraline Tablet 50 mg (as hydrochloride) Oral Zoloft 30 1.57 6.97